ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 249 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $22,451,000 | +4.8% | 379,682 | -13.8% | 0.08% | -1.2% |
| Q3 2020 | $21,423,000 | -4.5% | 440,539 | -5.0% | 0.09% | -13.1% |
| Q2 2020 | $22,426,000 | +8.5% | 463,539 | -37.7% | 0.10% | -22.0% |
| Q1 2020 | $20,661,000 | -38.1% | 743,734 | -33.3% | 0.13% | -28.2% |
| Q4 2019 | $33,373,000 | -7.3% | 1,115,411 | -4.3% | 0.18% | -27.8% |
| Q3 2019 | $36,011,000 | -36.0% | 1,165,411 | 0.0% | 0.24% | -36.0% |
| Q2 2019 | $56,289,000 | – | 1,165,411 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIGER MANAGEMENT L.L.C. | 1,115,411 | $45,576,000 | 7.97% |
| Rappaport Reiches Capital Management, LLC | 133,330 | $5,447,864 | 5.73% |
| Matrix Capital Management Company, LP | 11,800,090 | $482,152,000 | 5.27% |
| Asymmetry Capital Management, L.P. | 168,172 | $6,872,000 | 4.72% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $1,225,543,000 | 3.72% |
| Eagle Health Investments LP | 257,827 | $10,535,000 | 3.61% |
| BERYLSON CAPITAL PARTNERS, LLC | 246,200 | $10,060,000 | 2.23% |
| Aristotle Atlantic Partners, LLC | 717,650 | $29,323,000 | 1.93% |
| DDD Partners, LLC | 250,382 | $10,231,000 | 1.55% |
| Casdin Capital, LLC | 1,440,000 | $58,838,000 | 1.49% |